These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10837012)

  • 21. Prenylflavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidazo[4, 5-f]quinoline, mediated by cDNA-expressed human CYP1A2.
    Miranda CL; Yang YH; Henderson MC; Stevens JF; Santana-Rios G; Deinzer ML; Buhler DR
    Drug Metab Dispos; 2000 Nov; 28(11):1297-302. PubMed ID: 11038156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-Nitrosoamino-3-methylimidazo[4,5-f]quinoline stability and reactivity.
    Lakshmi VM; Hsu FF; Zenser TV
    Chem Res Toxicol; 2004 May; 17(5):709-16. PubMed ID: 15144229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of polyunsaturated fatty acids on prostaglandin synthesis and cyclooxygenase-mediated DNA adduct formation by heterocyclic aromatic amines in human adenocarcinoma colon cells.
    Moonen HJ; Dommels YE; van Zwam M; van Herwijnen MH; Kleinjans JC; Alink GM; de Kok TM
    Mol Carcinog; 2004 Jul; 40(3):180-8. PubMed ID: 15224350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-Nitrosoamino-3-methylimidazo[4,5-f]quinoline activated by the inflammatory response forms nucleotide adducts.
    Lakshmi VM; Schut HA; Zenser TV
    Food Chem Toxicol; 2005 Nov; 43(11):1607-17. PubMed ID: 15964673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetyl coenzyme A dependent activation of N-hydroxy derivatives of carcinogenic arylamines: mechanism of activation, species difference, tissue distribution, and acetyl donor specificity.
    Shinohara A; Saito K; Yamazoe Y; Kamataki T; Kato R
    Cancer Res; 1986 Sep; 46(9):4362-7. PubMed ID: 3731093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study.
    Edenharder R; Rauscher R; Platt KL
    Mutat Res; 1997 Sep; 379(1):21-32. PubMed ID: 9330619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-Acetyltransferase and sulfotransferase activity in human prostate: potential for carcinogen activation.
    Al-Buheissi SZ; Patel HR; Meinl W; Hewer A; Bryan RL; Glatt H; Miller RA; Phillips DH
    Pharmacogenet Genomics; 2006 Jun; 16(6):391-9. PubMed ID: 16708048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Food-derived mutagens and carcinogens.
    Wakabayashi K; Nagao M; Esumi H; Sugimura T
    Cancer Res; 1992 Apr; 52(7 Suppl):2092s-2098s. PubMed ID: 1544146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the human acetylation polymorphism in the metabolic activation of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ).
    Probst MR; Blum M; Fasshauer I; D'Orazio D; Meyer UA; Wild D
    Carcinogenesis; 1992 Oct; 13(10):1713-7. PubMed ID: 1423830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-Acetyltransferases, sulfotransferases and heterocyclic amine activation in the breast.
    Williams JA; Stone EM; Fakis G; Johnson N; Cordell JA; Meinl W; Glatt H; Sim E; Phillips DH
    Pharmacogenetics; 2001 Jul; 11(5):373-88. PubMed ID: 11470991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lactoperoxidase-catalyzed activation of carcinogenic aromatic and heterocyclic amines.
    Gorlewska-Roberts KM; Teitel CH; Lay JO; Roberts DW; Kadlubar FF
    Chem Res Toxicol; 2004 Dec; 17(12):1659-66. PubMed ID: 15606142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterocyclic amine-DNA adducts analyzed by 32P-postlabeling method.
    Yamashita K; Umemoto A; Grivas S; Kato S; Sato S; Sugimura T
    Nucleic Acids Symp Ser; 1988; (19):111-4. PubMed ID: 3067211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases.
    Flammang TJ; Kadlubar FF
    Carcinogenesis; 1986 Jun; 7(6):919-26. PubMed ID: 3708755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic activation of heterocyclic amine food mutagens in the mammary gland of lactating Fischer 344 rats.
    Davis CD; Ghoshal A; Schut HA; Snyderwine EG
    Cancer Lett; 1994 Aug; 84(1):67-73. PubMed ID: 7915639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimutagenic activity of spearmint.
    Yu TW; Xu M; Dashwood RH
    Environ Mol Mutagen; 2004; 44(5):387-93. PubMed ID: 15529323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.
    Lin D; Meyer DJ; Ketterer B; Lang NP; Kadlubar FF
    Cancer Res; 1994 Sep; 54(18):4920-6. PubMed ID: 8069858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of heterocyclic amines by combinations of prostaglandin H synthase-1 and -2 with N-acetyltransferase 1 and 2.
    Liu Y; Levy GN
    Cancer Lett; 1998 Nov; 133(1):115-23. PubMed ID: 9929169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA adduct formation of the food carcinogen 2-amino-3-methylimidazo[4,5- f]quinoline at the C-8 and N2 atoms of guanine.
    Turesky RJ; Markovic J
    Chem Res Toxicol; 1994; 7(6):752-61. PubMed ID: 7696529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocyclic amines.
    Suzuki A; Kushida H; Iwata H; Watanabe M; Nohmi T; Fujita K; Gonzalez FJ; Kamataki T
    Cancer Res; 1998 May; 58(9):1833-8. PubMed ID: 9581821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.